43-596 Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94
    ATCC c difficile strains
    C Difficile Strains, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c difficile strains/product/ATCC
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    c difficile strains - by Bioz Stars, 2024-07
    94/100 stars
      Buy from Supplier

    93
    ATCC c difficile atcc 43596
    Time-kill studies of CB-183,315 at 16× the MIC against three strains of C. difficile, including RMA 19139, a NAP1 strain from RM Alden Laboratory, ATCC 43596, a toxigenic clinical isolate, and ATCC 700057, a nontoxigenic strain used for susceptibility testing. MICs against CB-183,315 for these strains were 0.06 μg/ml for the NAP1 strain, 0.06 μg/ml for the toxigenic strain, and 0.25 μg/ml for the nontoxigenic strain. CB-183,315 was bactericidal against all three strains of C. difficile.
    C Difficile Atcc 43596, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c difficile atcc 43596/product/ATCC
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    c difficile atcc 43596 - by Bioz Stars, 2024-07
    93/100 stars
      Buy from Supplier

    86
    TechLab Inc ai 43596
    Time-kill studies of CB-183,315 at 16× the MIC against three strains of C. difficile, including RMA 19139, a NAP1 strain from RM Alden Laboratory, ATCC 43596, a toxigenic clinical isolate, and ATCC 700057, a nontoxigenic strain used for susceptibility testing. MICs against CB-183,315 for these strains were 0.06 μg/ml for the NAP1 strain, 0.06 μg/ml for the toxigenic strain, and 0.25 μg/ml for the nontoxigenic strain. CB-183,315 was bactericidal against all three strains of C. difficile.
    Ai 43596, supplied by TechLab Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ai 43596/product/TechLab Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ai 43596 - by Bioz Stars, 2024-07
    86/100 stars
      Buy from Supplier

    N/A
    Standard format Plasmid sent in bacteria as agar stab
      Buy from Supplier

    Image Search Results


    Time-kill studies of CB-183,315 at 16× the MIC against three strains of C. difficile, including RMA 19139, a NAP1 strain from RM Alden Laboratory, ATCC 43596, a toxigenic clinical isolate, and ATCC 700057, a nontoxigenic strain used for susceptibility testing. MICs against CB-183,315 for these strains were 0.06 μg/ml for the NAP1 strain, 0.06 μg/ml for the toxigenic strain, and 0.25 μg/ml for the nontoxigenic strain. CB-183,315 was bactericidal against all three strains of C. difficile.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: In Vitro and In Vivo Characterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile

    doi: 10.1128/AAC.00057-12

    Figure Lengend Snippet: Time-kill studies of CB-183,315 at 16× the MIC against three strains of C. difficile, including RMA 19139, a NAP1 strain from RM Alden Laboratory, ATCC 43596, a toxigenic clinical isolate, and ATCC 700057, a nontoxigenic strain used for susceptibility testing. MICs against CB-183,315 for these strains were 0.06 μg/ml for the NAP1 strain, 0.06 μg/ml for the toxigenic strain, and 0.25 μg/ml for the nontoxigenic strain. CB-183,315 was bactericidal against all three strains of C. difficile.

    Article Snippet: C. difficile ATCC 43596 (CB-183,315 MIC, 0.06 μg/ml) is a toxigenic clinical isolate from the feces of a patient in Belgium with pseudomembranous colitis.

    Techniques:

    Dose- and time-dependent efficacy of CB-183,315 (A) and vancomycin (B) against C. difficile ATCC 43596 in the hamster model of C. difficile-associated diarrhea (CDAD). Note that this animal model of CDAD is rapidly lethal for 100% of control hamsters dosed with deionized water; all five hamsters dosed with this vehicle were found dead on day 2. CB-183,315 and vancomycin produced similar patterns of dose- and time-dependent survival in this model. These data are from one of three studies comparing doses of CB-183,315 and vancomycin in this hamster model. Data from all three hamster studies are compared and compiled in Tables 2 and ​and33.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: In Vitro and In Vivo Characterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile

    doi: 10.1128/AAC.00057-12

    Figure Lengend Snippet: Dose- and time-dependent efficacy of CB-183,315 (A) and vancomycin (B) against C. difficile ATCC 43596 in the hamster model of C. difficile-associated diarrhea (CDAD). Note that this animal model of CDAD is rapidly lethal for 100% of control hamsters dosed with deionized water; all five hamsters dosed with this vehicle were found dead on day 2. CB-183,315 and vancomycin produced similar patterns of dose- and time-dependent survival in this model. These data are from one of three studies comparing doses of CB-183,315 and vancomycin in this hamster model. Data from all three hamster studies are compared and compiled in Tables 2 and ​and33.

    Article Snippet: C. difficile ATCC 43596 (CB-183,315 MIC, 0.06 μg/ml) is a toxigenic clinical isolate from the feces of a patient in Belgium with pseudomembranous colitis.

    Techniques: Animal Model, Produced